Combined with the ability of Bac5 to recruit macrophages and neutrophils, the stimulation of IFNγ production from alveolar macrophage-like cells suggests a potential therapeutic application for Bac5 in the treatment of tuberculosis. The gene discussed is IFNG; the disease is tuberculosis.